Atlas Trials

Kunming Pharmaceuticals, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kunming Pharmaceuticals, Inc.

RecordFirmDate
A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus (NCT07557927)Kunming Pharmaceuticals, Inc.2026-04-30
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects (NCT07422142)Kunming Pharmaceuticals, Inc.2026-03-01
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke (NCT07279493)Kunming Pharmaceuticals, Inc.2025-11-22
A Trial to Evaluate KPC000154 Tablets in Healthy Subjects (NCT06867406)Kunming Pharmaceuticals, Inc.2025-03-07
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors (NCT04906473)Kunming Pharmaceuticals, Inc.2021-07-31
Safety,Tolerability, and Pharmacokinetic of KPCXM18 for Injection (NCT04629287)Kunming Pharmaceuticals, Inc.2020-11-01
Exploratory Study of DHA in Systemic Lupus Erythematosus Patients (NCT03396393)Kunming Pharmaceuticals, Inc.2018-03-01

Track Kunming Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.